Sign Up to like & get
recommendations!
0
Published in 2018 at "Endocrinology"
DOI: 10.1210/en.2018-00368
Abstract: The cytoskeletal protein filamin A (FLNA) has been suggested to play an important role in the responsiveness of GH-secreting pituitary tumors to somatostatin receptor subtype 2 (SSTR2) agonists by regulating SSTR2 expression and signaling. However,…
read more here.
Keywords:
sstr2 clustering;
microscopy;
internalization;
flna interactions ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2023 at "Theranostics"
DOI: 10.7150/thno.77918
Abstract: Pheochromocytomas and paragangliomas (PCCs/PGLs) are catecholamine-producing tumors. In inoperable and metastatic cases, somatostatin type 2 receptor (SSTR2) expression allows for peptide receptor radionuclide therapy with [177Lu]Lu-DOTA-TATE. Insufficient receptor levels, however, limit treatment efficacy. This study…
read more here.
Keywords:
receptor radionuclide;
somatostatin type;
epigenetic drugs;
sstr2 ... See more keywords